Sample sizes for brain atrophy outcome measures in clinical trials for secondary progressive multiple sclerosis

被引：0

作者：

Altmann, Dan ^{[1
]}

Jasperse, B. ^{[2
]}

Barkhof, Frederik ^{[2
]}

Beckmann, Karola ^{[3
]}

Filippi, Massimo ^{[6
]}

Kappos, Ludwig ^{[4
]}

Molyneux, P. ^{[1
]}

Polman, Chris H. ^{[2
]}

Pozzilli, Carlo ^{[5
]}

Thompson, Alan J. ^{[1
]}

Wagner, Klaus ^{[3
]}

Yousry, Tarek ^{[1
]}

Miller, David H. ^{[1
]}

机构：

[1] UCL Inst Neurol, Med Ctr, London WC1N 3BG, England

[2] Vrije Univ Amsterdam, Amsterdam, Netherlands

[3] Bayer HealthCare, Berlin, Germany

[4] Univ Basel Hosp, CH-4031 Basel, Switzerland

[5] Univ Roma La Sapienza, Rome, Italy

[6] Univ Osped San Raffaele, Milan, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2008年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S22 / S22

页数：1

共 50 条

[1] Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis
Altmann, D. R.
Jasperse, B.
Barkhof, F.
Beckmann, K.
Filippi, M.
Kappos, L. D.
Molyneux, P.
Polman, C. H.
Pozzilli, C.
Thompson, A. J.
Wagner, K.
Yousry, T. A.
Miller, D. H.
[J]. NEUROLOGY, 2009, 72 (07) : 595 - 601
[2] Reliability of Outcome Measures in Clinical Trials in Secondary Progressive Multiple Sclerosis
Koch, Marcus W.
Mostert, Jop
Repovic, Pavle
Bowen, James D.
Uitdehaag, Bernard
Cutter, Gary
[J]. NEUROLOGY, 2021, 96 (01) : E111 - E120
[3] Imaging outcome measures for progressive multiple sclerosis trials
Moccia, Marcello
de Stefano, Nicola
Barkhof, Frederik
[J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (12) : 1614 - 1626
[4] Sample sizes for lesion magnetisation transfer ratio outcome measures in remyelination trials for multiple sclerosis
Altmann, D. R.
Button, T.
Schmierer, K.
Hunter, K.
Tozer, D.
Wheeler-Kingshott, C.
Coles, A.
Miller, D. H.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 470 - 470
[5] Brain atrophy as an outcome measure for multiple sclerosis clinical trials A "no-brainer"?
Rudick, Richard A.
Fisher, Elizabeth
[J]. NEUROLOGY, 2009, 72 (07) : 586 - 587
[6] Outcome measures in multiple sclerosis clinical trials
Andersson, PB
Goodkin, DE
[J]. BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
[7] Outcome Measures in Clinical Trials for Multiple Sclerosis
Caspar E. P. van Munster
Bernard M. J. Uitdehaag
[J]. CNS Drugs, 2017, 31 : 217 - 236
[8] Outcome Measures in Clinical Trials for Multiple Sclerosis
van Munster, Caspar E. P.
Uitdehaag, Bernard M. J.
[J]. CNS DRUGS, 2017, 31 (03) : 217 - 236
[9] Magnetic resonance imaging measures of brain and spinal cord atrophy correlate with clinical impairment in secondary progressive multiple sclerosis
Furby, J.
Hayton, T.
Anderson, V.
Altmann, D.
Brenner, R.
Chataway, J.
Hughes, R. A. C.
Smith, K. J.
Miller, D. H.
Kapoor, R.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (08) : 1068 - 1075
[10] Relationship between clinical outcome measures and progressive cerebral atrophy in relapsing remitting multiple sclerosis
Kinkel, RP
Fisher, E
Lee, JC
Simon, J
Jacobs, L
Rudick, R
[J]. NEUROLOGY, 1999, 52 (06) : A379 - A379

← 1 2 3 4 5 →